EIF2AK4 and cancer: These early therapeutic discoveries unknowingly enhanced the ISR activity: L-asparaginase converts asparagine to aspartic acid and ammonia, which triggers activation of GCN2 to drive cancer cells towards ISR-mediated apoptosis (30).